104048-92-2 | 4-(Trifluoromethyl)pyrimidin-2(1h)-one

Packsize	Purity	Availability	Price	Discounted Price
25g	98%	in stock	$14.00	$10.00

Description

• Catalog Number: AB62312
• Chemical Name: 4-(Trifluoromethyl)pyrimidin-2(1h)-one
• CAS Number: 104048-92-2
• Molecular Formula: C5H3F3N2O
• Molecular Weight: 164.0853
• MDL Number: MFCD00192529
• SMILES: O=c1[nH]ccc(n1)C(F)(F)F

Computed Properties

• Complexity: 241
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 1
• XLogP3: -0.9

Upstream Synthesis Route

4-(Trifluoromethyl)pyrimidin-2(1H)-one, commonly referred to as $name$, is a versatile compound widely utilized in chemical synthesis for its unique properties and reactivity. Due to the presence of the trifluoromethyl group, this compound serves as a valuable building block in organic synthesis, particularly in the pharmaceutical industry.In chemical synthesis, $name$ is frequently employed as a key intermediate in the preparation of various biologically active molecules, pharmaceuticals, and agrochemicals. Its trifluoromethyl group enhances the lipophilicity and metabolic stability of the resulting compounds, making them promising candidates for drug development.Furthermore, the presence of the pyrimidine ring in $name$ imparts favorable electronic properties, allowing for efficient manipulation of its chemical reactivity in diverse synthetic transformations. This enables chemists to introduce functional groups at specific positions on the pyrimidine ring, thereby enabling the synthesis of complex molecules with high precision and selectivity.Overall, the application of 4-(Trifluoromethyl)pyrimidin-2(1H)-one in chemical synthesis showcases its significance as a valuable tool for building intricate molecular architectures with potential applications in the pharmaceutical and agrochemical industries.

Literature

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101